Combination of HER2-targeted antibodies (Trastuzumab plus Pertuzumab) is effective against HER2 amplified ovarian cancer xenograft models

S. P. Langdon; A. H. Sims; D. J. Harrison

Combination of HER2-targeted antibodies (Trastuzumab plus Pertuzumab) is effective against HER2 amplified ovarian cancer xenograft models

S. P. Langdon, A. H. Sims, D. J. Harrison

School of Medicine

Research output: Contribution to journal › Abstract › peer-review

Original language	English
Pages (from-to)	25
Number of pages	1
Journal	Journal of Pathology
Volume	231
Publication status	Published - Sept 2013
Event	7th Joint Meeting of the British-Division of the International-Academy-of-Pathology and the Pathological-Society-of-Great-Britain-and-Ireland - , United Kingdom Duration: 18 Jun 2013 → 21 Jun 2013

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Cite this

@article{49cc3def8e564f208cd5e53902e238cc,

title = "Combination of HER2-targeted antibodies (Trastuzumab plus Pertuzumab) is effective against HER2 amplified ovarian cancer xenograft models",

author = "Langdon, \{S. P.\} and Sims, \{A. H.\} and Harrison, \{D. J.\}",

note = "M1 - Meeting abstract; 7th Joint Meeting of the British-Division of the International-Academy-of-Pathology and the Pathological-Society-of-Great-Britain-and-Ireland ; Conference date: 18-06-2013 Through 21-06-2013",

year = "2013",

month = sep,

language = "English",

volume = "231",

pages = "25",

journal = "Journal of Pathology",

issn = "0022-3417",

publisher = "John Wiley \& Sons, Ltd",

}

TY - JOUR

T1 - Combination of HER2-targeted antibodies (Trastuzumab plus Pertuzumab) is effective against HER2 amplified ovarian cancer xenograft models

AU - Langdon, S. P.

AU - Sims, A. H.

AU - Harrison, D. J.

N1 - M1 - Meeting abstract

PY - 2013/9

Y1 - 2013/9

M3 - Abstract

SN - 0022-3417

VL - 231

SP - 25

JO - Journal of Pathology

JF - Journal of Pathology

T2 - 7th Joint Meeting of the British-Division of the International-Academy-of-Pathology and the Pathological-Society-of-Great-Britain-and-Ireland

Y2 - 18 June 2013 through 21 June 2013

ER -